Latest News

PQ Bypass Unveils New Data From DETOUR I at VIVA17.

12 September 2017.  Seroba's investee company, PQ Bypass, today announced data from a subset analysis of the DETOUR I clinical trial during a late-breaking clinical trial session at Vascular InterVentional Advances (VIVA 17), which is taking place September 11-14 in Las Vegas. The study evaluated the safety and effectiveness of the DETOUR System for treating long-segment (;...


SENTRY Vena Cava Filter Yields Zero Pulmonary Embolisms at 12 Months.

Galway, Ireland - 12 September 2017.  Clinical trial results for Novate's SENTRY device were presented by Principal Investigator, Michael Dake MD of Stanford University in California at the 15th Annual Conference on Vascular Interventional Advances (VIVA17), which has been taking place in Las Vegas. SENTRY is a prospective, single-arm, multi-centre registry trial in which the...


Mimics Study’s Outcomes Announced at VIVA17.

Professor Thomas Zeller MD announced new significant outcomes from the Mimics Study today, September 12th, 2017, at the 15th Annual Conference on Vascular Interventional Advances (VIVA17) in Las Vegas, NV. The BioMimics 3D Vascular Stent with unique helical curvature to generate swirling blood flow was evaluated in the Mimics Study, which randomised 76 patients with symptomatic peripheral...


< back to home page